Ad is loading...
GCVAX
Price
$27.12
Change
-$0.15 (-0.55%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

GCVAX vs VIVIX

Header iconGCVAX vs VIVIX Comparison
Open Charts GCVAX vs VIVIXBanner chart's image
Goldman Sachs Large Cp Val Insghts A
Price$27.12
Change-$0.15 (-0.55%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
GCVAX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCVAX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVAX is a StrongBuy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. GCVAX (398M). VIVIX pays higher dividends than GCVAX: VIVIX (2.37) vs GCVAX (1.02). GCVAX was incepted earlier than VIVIX: GCVAX (26 years) vs VIVIX (26 years). GCVAX is a more actively managed with annual turnover of: 208.00 vs. VIVIX (10.00). GCVAX has a lower initial minimum investment than VIVIX: GCVAX (1000) vs VIVIX (5000000). GCVAX (26.31) and VIVIX (25.54) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. GCVAX (30.18).
GCVAXVIVIXGCVAX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years26 years-
Gain YTD20.99717.922117%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets398M184B0%
Annual Yield % from dividends1.022.3743%
Returns for 1 year26.3125.54103%
Returns for 3 years1.4721.577%
Returns for 5 years30.1850.7959%
Returns for 10 years73.98110.5067%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPEAX45.40-0.23
-0.50%
Davis Opportunity A
CSDGX16.39-0.15
-0.91%
Copeland SMID Cap Dividend Growth A
LGLCX39.13-0.68
-1.71%
Lord Abbett Growth Leaders C
DWOIX20.65-0.48
-2.27%
BNY Mellon Research Growth I
RYHAX35.08-0.82
-2.28%
Rydex Health Care H